Correlation Between Neovacs SA and EssilorLuxottica

Can any of the company-specific risk be diversified away by investing in both Neovacs SA and EssilorLuxottica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neovacs SA and EssilorLuxottica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neovacs SA and EssilorLuxottica S A, you can compare the effects of market volatilities on Neovacs SA and EssilorLuxottica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neovacs SA with a short position of EssilorLuxottica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neovacs SA and EssilorLuxottica.

Diversification Opportunities for Neovacs SA and EssilorLuxottica

-0.82

Correlation Coefficient

Neovacs SA  EssilorLuxottica

Pay attention - limited upside

The 3 months correlation between Neovacs and EssilorLuxottica is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Neovacs SA and EssilorLuxottica S A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EssilorLuxottica S and Neovacs SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neovacs SA are associated (or correlated) with EssilorLuxottica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EssilorLuxottica S has no effect on the direction of Neovacs SA i.e., Neovacs SA and EssilorLuxottica go up and down completely randomly.

Pair Corralation between Neovacs SA and EssilorLuxottica

Assuming the 90 days trading horizon Neovacs SA is expected to generate 23.02 times more return on investment than EssilorLuxottica. However, Neovacs SA is 23.02 times more volatile than EssilorLuxottica S A. It trades about 0.06 of its potential returns per unit of risk. EssilorLuxottica S A is currently generating about 0.14 per unit of risk. If you would invest  0.07  in Neovacs SA on September 5, 2024 and sell it today you would lose (0.04) from holding Neovacs SA or give up 57.14% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Neovacs SA  vs.  EssilorLuxottica S A

Neovacs SA

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neovacs SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Neovacs SA reported solid returns over the last few months and may actually be approaching a breakup point.

EssilorLuxottica S

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in EssilorLuxottica S A are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, EssilorLuxottica may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Neovacs SA and EssilorLuxottica

The main advantage of trading using opposite Neovacs SA and EssilorLuxottica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neovacs SA position performs unexpectedly, EssilorLuxottica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EssilorLuxottica will offset losses from the drop in EssilorLuxottica's long position.

The idea behind Neovacs SA and EssilorLuxottica S A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.